These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38878487)

  • 1. CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway.
    Li K; Lv J; Wang J; Wei Y; Zhang Y; Lin J; Zhu Q
    Int Immunopharmacol; 2024 Aug; 137():112485. PubMed ID: 38878487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
    Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q
    Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    Lv J; Li K; Yu H; Han J; Zhuang J; Yu R; Cheng Y; Song Q; Bai K; Cao Q; Yang H; Yang X; Lu Q
    J Exp Clin Cancer Res; 2023 Feb; 42(1):41. PubMed ID: 36747239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer.
    Li Y; Wang Z; Gao P; Cao D; Dong R; Zhu M; Fei Y; Zuo X; Cai J
    J Transl Med; 2024 Jul; 22(1):704. PubMed ID: 39080693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
    Lv J; Wu Q; Li K; Bai K; Yu H; Zhuang J; Sun H; Yang H; Yang X; Lu Q
    Int J Biol Sci; 2023; 19(12):3744-3761. PubMed ID: 37564199
    [No Abstract]   [Full Text] [Related]  

  • 8. Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis.
    Fan L; Yang J; Shen C; Wu Z; Hu H
    Acta Histochem; 2021 Jul; 123(5):151745. PubMed ID: 34175686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A reader IGF2BP2 promotes M2 macrophage polarization and malignant biological behavior of bladder cancer by stabilizing NRP1 mRNA expression.
    Fu D; Shi X; Yi X; Wu D; He H; Zhou W; Cheng W
    BMC Urol; 2024 Jul; 24(1):147. PubMed ID: 39014364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.
    Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X
    Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy.
    Chen Z; Hu J; Ou Y; Ye F; Li W; Liu S; Jiang H
    Front Immunol; 2024; 15():1427124. PubMed ID: 39238647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0005320 affects cell proliferation and the cell cycle via the IGF2BP3/CDK2 axis in bladder cancer.
    Ji Q; Ma F; Zhang X; Liu Y; Wang P; Li M
    Cell Signal; 2024 Jul; 119():111154. PubMed ID: 38565412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H
    Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircZNF609/miR-134-5p/BTG-2 axis regulates proliferation and migration of glioma cell.
    Tong H; Zhao K; Wang J; Xu H; Xiao J
    J Pharm Pharmacol; 2020 Jan; 72(1):68-75. PubMed ID: 31721211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response.
    Zhang Y; Li Z; Zhang Y; Shen C; Zhang Z; Ren X; Guo C; Yang S; Wang Z; Hu H
    Cell Transplant; 2023; 32():9636897231165874. PubMed ID: 37026617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment.
    Yang C; Ou Y; Zhou Q; Liang Y; Li W; Chen Y; Chen W; Wu S; Chen Y; Dai X; Chen X; Chen T; Jin S; Liu Y; Zhang L; Liu S; Hu Y; Zou L; Mao S; Jiang H
    Cell Death Dis; 2023 Aug; 14(8):525. PubMed ID: 37582769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma.
    Liu Q; Cui W; Yang C; Du LP
    Aging (Albany NY); 2021 Aug; 13(15):19822-19834. PubMed ID: 34370715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs.
    Shi X; Pang S; Zhou J; Yan G; Gao R; Wu H; Wang Z; Wei Y; Liu X; Tan W
    Mol Cancer; 2024 Mar; 23(1):52. PubMed ID: 38461272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma.
    Shang Q; Du H; Wu X; Guo Q; Zhang F; Gong Z; Jiao T; Guo J; Kong Y
    J Exp Clin Cancer Res; 2022 May; 41(1):170. PubMed ID: 35534866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.